Lemon Company

Lemonaid Health is a leading technology-driven telehealth company that provides patients with direct access to medical care and prescription medications through a streamlined digital platform. Founded in 2013 and headquartered in San Francisco, the company offers a wide range of services including consultations for primary care, mental health, and chronic condition management. In November 2021, Lemonaid Health was acquired by 23andMe for approximately $400 million to integrate personalized genetic insights into clinical care. The platform leverages a team of licensed clinicians to provide evidence-based medical services, focusing on affordability and convenience. Recently, the company expanded its offerings to include a GLP-1 weight loss membership, providing access to medications like semaglutide.